H
Hospital Evangelico De Cachoeiro de Itapemirim | Centro de Pesquisas Clinicas em Oncologia
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Pembrolizumab
Nivolumab
5-Fluorouracil
Binimetinib
Irinotecan
Tislelizumab
Bemarituzumab
MEDI4736
Cetuximab
Encorafenib
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 5 total trials
The purpose of this study is to evaluate the efficacy and safety of ociperlimab + tislelizumab compared with that of pembrolizumab in adults with PD-...
Active, not recruiting
Non-small Cell Lung Cancer
NSCLC
Drug: Placebo
Drug: Tislelizumab
Locations recently updated
The main objective of Part 1 is to evaluate the safety and tolerability of bemarituzumab plus 5-fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6)...
Enrolling
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Other: Placebo
Drug: Nivolumab
The primary objective of this study is to compare the effect of zimberelimab (ZIM) and domvanalimab (DOM) in combination with chemotherapy relative t...
Enrolling
Non-small Cell Lung Cancer
Drug: Domvanalimab
Drug: Nab-paclitaxel
Trial sponsors
C
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems